209 related articles for article (PubMed ID: 10967748)
1. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis.
Tabet N; Mantle D; Orrell M
Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
4. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
Wang X; Su B; Perry G; Smith MA; Zhu X
Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
Chen X; Yan SD
IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
[TBL] [Abstract][Full Text] [Related]
6. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
7. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.
Veurink G; Fuller SJ; Atwood CS; Martins RN
Ann Hum Biol; 2003; 30(6):639-67. PubMed ID: 14675907
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
Chen JX; Yan SD
Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
[TBL] [Abstract][Full Text] [Related]
11. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
13. Free radical oxidative damage and Alzheimer's disease.
Tuppo EE; Forman LJ
J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 1):S11-5. PubMed ID: 11794746
[TBL] [Abstract][Full Text] [Related]
14. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
Swerdlow RH; Khan SM
Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
Crouch PJ; Barnham KJ; Bush AI; White AR
Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
[TBL] [Abstract][Full Text] [Related]
16. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
Atwood CS; Huang X; Moir RD; Tanzi RE; Bush AI
Met Ions Biol Syst; 1999; 36():309-64. PubMed ID: 10093929
[No Abstract] [Full Text] [Related]
17. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.
Sayre LM; Zagorski MG; Surewicz WK; Krafft GA; Perry G
Chem Res Toxicol; 1997 May; 10(5):518-26. PubMed ID: 9168248
[No Abstract] [Full Text] [Related]
18. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
19. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
Montalto MC; Farrar G; Hehir CT
Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
Atamna H; Frey WH
Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]